This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Saikku, P., Leinonen, M., Matilla, K., el al., 1988, Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet 2:983–986.
Frothingham, C., 1911, The relationship between acute infectious diseases and arterial lesions, Arch. Intern. Med. 8:153–162.
Kalayoglu, M. V., Libby, P., and Byrne, G. I., 2002, Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease, JAMA 288:2724–2731.
Kol, A., Sukhova, G. K., Lichtman, A. H., and Libby, P., 1998, Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression, Circulation 98:300–307.
Kalayoglu, M. V., Hoerneman, B., LaVerda, D., Morrison, S. G., Morrison, R. P., and Byrne, G. I., 1999, Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae, J. Infect. Dis. 180:780–790.
Kalayoglu, M. V., and Byrne, G. I., 1998, Induction of macrophage foam cell formation by Chlamydia pneumoniae, J. Infect. Dis. 177:725–729.
Byrne, G. I., and Kalayoglu, M. V., 1999, Chlamydia pneumoniae and atherosclerosis: Links to the disease process, Am. Heart J. 138:S488–S490.
Kalman, S., Mitchell, W., Marathe, R., Lammel, C., Fan, J., Hyman, R. W., Olinger, L., Grimwood, J., Davis, R. W., and Stephens, R. S., 1999, Comparative genomes of Chlamydia pneumoniae and C. trachomatis, Nat. Genet. 21:385–389.
Read, T. D., Brunham, R. C., Shen, C., Gill, S. R., Heidelberg, J. F., White, O., Hickey, E. K., Peterson, J., Utterback, T., Berry, K, Bass, S., Linher, K, Weidman, J., Khouri, H., Craven, B., Bowman, C., Dodson, R., Gwinn, M., Nelson, W., DeBoy, R., Kolonay, J., McClarty, G., Salzberg, S. L., Eisen, J., and Fraser, C. M., 2000, Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39, Nucleic Acids Res. 28:1397–1406.
Shirai, M., Hirakawa, H., Kimoto, M., Tabuchi, M., Kishi, F., Ouchi, K., Shiba, T., Ishii, K., Hattori, M., Kuhara, S., and Nakazawa, T., 2000, Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA, Nucleic Acids Res. 28:2311–2314.
Gieffers, J., Belland, R.J., Whitmire, W., Ouellette, S., Crane, D., Maass, M., Byrne, G. I., and Caldwell, H. D., 2002, Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay, Infect. Immun. 70:5827–5834.
Beatty, W. L., Morrison, R. P., and Byrne, G. I., 1994, Persistent Chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis, Microbiol. Rev. 58:686–699.
Carabeo, R. A., and Hackstadt, T., 2001, Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process, Infect. Immun. 69:5899–5904.
Van Ooij, C., Apodaca, G., and Engel, J., 1997, Characterization of Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells, Infect. Immun. 65:758–766.
Wolf, K., and Hackstadt, T., 2001, Sphingomyelin trafficking in Chlamydia pneumoniae- infected cells, Cell, Micmbiol. 3:145–152.
Byrne, G. I., Ouellette, S. P., Wang, Z., Rao, J. P., Lu, L., Beatty, W. L., and Hudson, A. P., 2001, Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells, Infect. Immun. 69:5423–5429.
Ramsey, K. H., Miranpuri, G. S., Sigar, I. M., Ouellette, S., and Byrne, G. I., 2001, Chlamydia trachomatis persistence in the female mouse genital tract: Inducible nitric oxide synthase and infection outcome, Infect. Immun. 69:5131–5137.
Miller, S. A., Selzman, C. H., Shames, B. D., Barton, H. A., Johnson, S. M., and Harken, A. H., 2000, Chlamydia pneumoniae activates nuclear factor kB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation, J. Surg. Res. 90:76–81.
Dechend, R., Maass, M., Gieffers, J., Dietz, R., Scheidereit, C., Leutz, A., and Gulba, D. C., 1999, Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kB and induces tissue factor and PAI-1 expression, Circulation 100:1369–1373.
Fryer, R. H., Schwobe, E. P., Woods, M. L., and Rodgers, G. M., 1997, Chlamydia species infect human vascular endothelial cells and induce procoagulant activity, J. Invest. Med. 45:168–174.
Coombes, B. K., and Mahony, J. B., 1999, Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s), Infect. Immun. 67:2909–2915.
Molestina, R. E., Miller, R. D., Ramirez, J. A., and Summersgill, J. T., 1999, Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes, Infect. Immun. 67:1323–1330.
Molestina, R. E., Dean, D., Miller, R. D., Ramirez, J. A., and Summersgill, J. T., 1998, Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells, Infect. Immun. 66:1370–1376.
Coombes, B. K, and Mahony, J. B., 2001, cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection, Infect. Immun. 69:1420–1427.
Kothe, H., Dalhoff, K., Rupp, J., Muller, A., Kreuzer, J., Maass, M., and Katus, H. A., 2000, Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae, Circulation 101:1760–1763.
Krull, M., Klucken, A. C., Wuppermann, F. N., Fuhrmann, O., Magerl, C., Seybold, J., Hippenstiel, S., Hegemann, J. H., Jantos, C. A., and Suttorp, N., 1999, Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae, J. Immunol. 162:4834–4841.
Kalayoglu, M. V., Indrawati, Morrison, R. P., Morrison, S. G., Yuan, Y, and Byrne, G. I., 2000, Chlamydial virulence determinants in atherogenesis: The role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions, J. Infect. Dis. 181(Suppl. 3):S483–S489.
LaVerda, D., Albanese, L. N., Ruther, P. E., Morrison, S. G., Morrison, R. P., Ault, K. A., and Byrne, G. I., 2000, Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease, Infect. Immun. 68:303–309.
Kalayoglu, M. V., and Byrne, G. I., 1998, A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide, Infect. Immun. 66:5067–5072.
Beatty, W. L., Byrne, G. I., and Morrison, R. P., 1993, Morphological and antigenic characterization of interferon-gamma mediated persistent Chlamydia trachomatis infection in vitro, Proc. Natl. Acad. Sci. U.S.A. 90:3998–4002.
Byrne, G. I., Lehmann, L. K., and Landry, G. J., 1986, Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells, Infect. Immun. 53:347–351.
Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A., and Quinn, T. C., 1996, Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells, Infect. Immun. 64:1614–1620.
Haranaga, S., Yamaguchi, H., Friedman, H., Izumi, S.-I., and Yamamoto, Y., 2001, Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro, Infect. Immun. 69:7753–7759.
Moazed, T. C., Kuo, C., Grayston, J. T., and Campbell, L. A., 1997, Murine models of Chlamydia pneumoniae infection and atherosclerosis, J. Infect. Dis. 175:883–890.
Yamaguchi, H., Haranaga, S., Widen, R., Friedman, H., and Yamamoto, Y, 2002, Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages, Infect. Immun. 70:2392–2398.
Kalayoglu, M. V., Perkins, B. N., and Byrne, G. I., 2001, Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells, Microb. Infect. 3:963–969.
Grimwood, J., Olinger, L., and Stephens, R. S., 2001, Expression of Chlamydia pneumoniae polymorphic membrane protein family genes, Infect. Immun. 69:2383–2389.
Vandahl, B. B., Birkelund, S., Demol, H., Hoorelbeke, B., Christiansen, G., Vandekerckhove, J., and Gevaert, K., 2001, Proteome analysis of the Chlamydia pneumoniae elementary body, Electrophoresis 22:1204–1223.
Montigiani, S., Falugi, F., Scarselli, M., Finco, O., Petracca, R., Galli, G., Mariani, M., Manetti, R., Agnusdei, M., Cevenini, R., Donati, M., Nogarotto, R., Norais, N., Garaguso, I., Nuti, S., Saletti, G., Rosa, D., Ratti, G., and Grandi, G., 2002, Genomic approach for analysis of surface proteins in Chlamydia pneumoniae, Infect, Immun. 70:368–379.
Rocha, E. P. C., Pradillon, O., Bui, H., Sayada, C., and Denamur, E., 2002, A new family of highly variable proteins in the Chlamydophila pneumoniae genome, Nucleic Acids Res. 30:4351–4360.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Ouellette, S.P., Belland, R.J., Gieffers, J., Byrne, G.I. (2005). The Biology of Chlamydia pneumoniae in Cardiovascular Disease Pathogenesis. In: Friedman, H., Yamamoto, Y., Bendinelli, M. (eds) Chlamydia pneumoniae Infection and Disease. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-48741-1_10
Download citation
DOI: https://doi.org/10.1007/0-306-48741-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48487-2
Online ISBN: 978-0-306-48741-5
eBook Packages: Springer Book Archive